Australian Clinical Labs (ASX:ACL) — Material Events
ASX:ACL · 8 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
ACL Delivers Earnings Growth Amid Market Challenges and Wage PressuresMedium
ACL reports 1H26 earnings growth despite revenue dip; updates FY26 guidance and addresses wage impacts
16 Feb 2026
·Financial Results
·85
Australian Clinical Labs Delivers Solid FY25 Growth and Boosts DividendMedium
Australian Clinical Labs posts strong FY25 results, raises dividend, and provides positive FY26 guidance
26 Aug 2025
·Financial Results
·85
Australian Clinical Labs Boosts Revenue and Margins Amid Industry ChallengesMedium
Australian Clinical Labs FY25 revenue up 6.4%, underlying EBIT up 8.7%, declares 9c final dividend
26 Aug 2025
·Annual Financial Report
·85
Australian Clinical Labs Accelerates Growth with AI and Genomic Testing in FY25Medium
Australian Clinical Labs posts strong FY25 results, raises FY26 guidance, advances AI and genomic testing initiatives
26 Aug 2025
·Financial Results
·85
Australian Clinical Labs Names Greg Horan as New CEO to Succeed Melinda McGrathMedium
Australian Clinical Labs appoints Greg Horan as new Group CEO effective August 2026
28 May 2026
·Executive Appointment
·75
Australian Clinical Labs Launches 10% Share Buy-Back to Boost Shareholder ValueMedium
Australian Clinical Labs launches 12-month on-market share buy-back of up to 10% of shares
23 Oct 2025
·Capital Management
·75
Australian Clinical Labs Faces New Class Action Over 2022 Medlab CyberattackMedium
Australian Clinical Labs faces class action over 2022 Medlab Pathology cyberattack
21 Apr 2026
·Legal Proceedings Announcement
·Unexpected
·70
ACL Agrees to $6.2M Settlement Over Medlab Cyberattack Privacy BreachMedium
ACL settles Privacy Act proceeding over Medlab cyberattack with $6.2 million penalty agreement
29 Sept 2025
·Regulatory Update
·65
No articles in this tier for the last 12 months.
Market Mentions
3
- appeared in market wrap coverage
These are market wrap articles where Australian Clinical Labs (ASX:ACL) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Healthcare Wrap - Week 17 (20 Apr -> 24 Apr) 2026
25 Apr 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026